Weight loss surgery for non-morbidly obese populations with type 2 diabetes: is this an acceptable option for patients?

Abstract

Aim To explore the views of non-morbidly obese people (BMI 30-40 kg/m2) with type 2 diabetes regarding: (a) the acceptability of bariatric surgery (BS) as a treatment for type 2 diabetes, and (b) willingness to participate in randomised controlled trials comparing BS versus non-surgical intervention. BACKGROUND: Despite weight management being a key therapeutic goal in type 2 diabetes, achieving and sustaining weight loss is problematic. BS is an effective treatment for people with morbid obesity and type 2 diabetes; it is less certain whether non-morbidly obese patients (BMI 30-39.9 kg/m2) with type 2 diabetes benefit from this treatment and whether this approach would be cost-effective. Before evaluating this issue by randomised trials, it is important to understand whether BS and such research are acceptable to this population. METHODS: Non-morbidly obese people with type 2 diabetes were purposively sampled from primary care and invited to participate in semi-structured interviews. Interviews explored participants' thoughts surrounding their diabetes and weight, the acceptability of BS and the willingness to participate in BS research. Data were analysed using Framework Analysis

More information

Identifiers

ORCID for Rachael H. Summers: orcid.org/0000-0001-9060-0584

ORCID for Michael Moore: orcid.org/0000-0002-5127-4509

ORCID for Christopher Byrne: orcid.org/0000-0001-6322-7753

ORCID for Paul Roderick: orcid.org/0000-0001-9475-6850

Catalogue record

Export record

Altmetrics